Company | The Hershey Company |
Ticker | HSY |
Reporting Period | Q2 2026 (quarter ending June 30, 2026) |
Last Earnings | Q1 2026 — reported April 30, 2026 |
Preparation Date | July 29, 2026 |
Sector ETF Used | XLP (Consumer Staples Select Sector SPDR) |
Key Takeaway: The setup is cautiously constructive but not a high bar — consensus expects slightly negative NA Confectionery organic sales in Q2 (−1.9% vs. +8.0% actual in Q1) due to a well-telegraphed shipment timing pull-forward, making the real swing factor whether gross margin expansion of ~300 bps materializes as guided and whether management upgrades full-year guidance at the midyear mark.
Heading into Q2 2026, the bar for Hershey is deliberately set low on the top line: management guided North America Confectionery organic sales to be slightly negative due to the Easter timing pull-forward that shifted spring programming (including S'mores) into Q1, and consensus has aligned at approximately −1.9% organic growth for the segment. The more important metric is gross margin, where management guided ~300 bps of year-over-year expansion in Q2 and >500 bps in H2 as higher-cost cocoa is lapped — this is the crux of the 2026 recovery narrative and any shortfall here would be the most damaging outcome. Estimate revisions have been essentially flat since the Q1 print, with consensus net sales for Q2 at $2.64B (vs. $2.61B actual in Q2 2025) and adjusted EPS at $1.43, suggesting the street is not pricing in a meaningful beat or miss. The stock has underperformed XLP by roughly 4–5 points since the Q1 earnings date and trades near the low end of its post-earnings range, implying the market is not pricing in a positive surprise. The single biggest wildcard is whether management raises full-year 2026 guidance at the midyear mark — they explicitly flagged this as the decision point on the Q1 call — which would be the most meaningful catalyst for the stock given the current cautious posture.
Key Takeaway: Consensus is a low bar on revenue (organic sales expected slightly negative due to timing) but a meaningful bar on gross margin (~300 bps expansion guided) — gross margin is the bigger swing factor for the stock on print day.
KPI | Q1 2026 Actual (Last Quarter) | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance (Q1 Call) | Consensus vs. Guidance |
Net Sales ($B) | $3.10B | $2.61B | $2.64B | +1.0% YoY | Slightly negative organic (NA Confectionery); no explicit total sales $ guide | Consistent with guidance |
Adj. EPS (Diluted Operating) | $2.35 | $1.21 | $1.43 | +18.2% YoY | No explicit Q2 EPS guide; FY2026 guide implies recovery | N/A (no Q2 EPS guide) |
Gross Profit - Operating ($B) | $1.25B | $0.997B | $1.08B | +8.5% YoY | ~+300 bps gross margin expansion YoY in Q2 | Consistent with ~300 bps guide |
Operating Income - Operating ($M) | $686M | $411M | $452M | +10.1% YoY | No explicit Q2 guide; double-digit A&M spend increase expected | N/A |
NA Confectionery Sales ($B) | $2.49B | $2.09B | $2.05B | −1.8% YoY | Slightly negative organic due to Easter timing pull-forward | Consistent with guidance |
NA Confectionery Organic Growth (%) | +8.0% | +31.6% | −1.9% | ~−33 pts YoY (base effect + timing) | Slightly negative (explicit guidance) | Consistent with guidance |
NA Salty Snacks Sales ($M) | $350M | $316M | $379M | +20.0% YoY | Core branded salty up ~10%; private label drag ongoing | Consistent with guidance |
NA Salty Snacks Organic Growth (%) | +5.0% | +8.8% | +4.2% | −4.6 pts YoY | Core brands up ~10%; private label reduction drag | Consistent with guidance |
Operating Margin - Operating (%) | 22.1% | 15.7% | 17.2% | +150 bps YoY | Gross margin +300 bps; operating margin will lag due to double-digit A&M ramp | Consistent with guidance |
Source: Visible Alpha Consensus and Actuals Data. All consensus figures as of July 29, 2026.
Top 2 KPIs: Net Sales and Adjusted EPS (Diluted Operating)
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Net Sales | $3.104B | $3.033B | +2.3% | Beat |
Q1 2026 | Adj. EPS | $2.35 | $2.04 | +15.2% | Beat |
Q4 2025 | Net Sales | $3.091B | $2.976B | +3.9% | Beat |
Q4 2025 | Adj. EPS | $1.71 | $1.39 | +23.0% | Beat |
Q3 2025 | Net Sales | $3.181B | $3.113B | +2.2% | Beat |
Q3 2025 | Adj. EPS | $1.30 | $1.06 | +22.6% | Beat |
Q2 2025 | Net Sales | $2.615B | $2.537B | +3.1% | Beat |
Q2 2025 | Adj. EPS | $1.21 | $1.03 | +17.5% | Beat |
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2025 | Net Sales | $2.805B | $2.807B | -0.1% | Miss |
Q1 2025 | Adj. EPS | $2.09 | $1.94 | +7.2% | Beat |
Q4 2024 | Net Sales | $2.888B | $2.841B | +1.7% | Beat |
Q4 2024 | Adj. EPS | $2.69 | $2.35 | +14.5% | Beat |
Q3 2024 | Net Sales | $2.987B | $3.075B | -2.9% | Miss |
Q3 2024 | Adj. EPS | $2.34 | $2.58 | -9.3% | Miss |
Q2 2024 | Net Sales | $2.074B | $2.314B | -10.4% | Miss |
Q2 2024 | Adj. EPS | $1.27 | $1.48 | -14.2% | Miss |
Pattern: HSY has beaten on both Net Sales and Adj. EPS in 5 of the last 6 quarters (Q1 2025 was a narrow revenue miss). The two double-misses (Q2 and Q3 2024) coincided with peak cocoa cost pressure; that headwind is now reversing, supporting continuation of the beat pattern. EPS beats have been consistently large (7-23%), reflecting management's conservative guidance posture.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Full-year 2026 guidance was reaffirmed unchanged after the Q1 beat; management explicitly flagged the midyear mark (Q2 print) as the decision point for a potential guidance raise, making this earnings call the most important catalyst event of the year.
Metric | Initial Guidance (Q1 2026 Call, Apr 30) | Revised Guidance | Current Consensus | Note |
FY2026 Net Sales Growth | Within prior guidance range (2-4% algorithm) | +1.3% YoY ($12.24B) | No post-earnings update; guidance unchanged | |
FY2026 Adj. EPS | Reaffirmed prior range; mid-teens growth off depressed 2025 base | $8.43 | No post-earnings update; management deliberately held guide despite Q1 beat | |
Q2 2026 NA Confectionery Organic Sales | Slightly negative (explicit Q2 guide due to Easter timing pull-forward) | -1.9% | Consensus aligned with guidance; timing-driven, not structural | |
Q2 2026 Gross Margin (Operating) | ~+300 bps YoY expansion | ~41.1% (implied from consensus gross profit / sales) | Key metric for Q2; consensus tracking guidance; H2 guide is >500 bps expansion | |
FY2026 Marketing & Advertising (SM&A) | Double-digit increase YoY; some Q1 non-working media slipped to Q2 | N/A (not separately tracked in consensus) | Operating margin will lag gross margin improvement in Q2 and H2 due to A&M ramp | |
Pricing Strategy | No additional pricing in 2026; focus on executing current pricing and supply chain optimization | N/A | Consistent; competitive environment described as 'highly rational' | |
Guidance Raise Decision | Explicitly deferred to midyear mark (Q2 print) | N/A | Most important catalyst: management said 'by the time we get to the midyear mark, we'll have a lot more visibility' |
Key Takeaway: Estimates have been essentially flat since the Q1 print — the street is tracking guidance closely with no meaningful divergence, suggesting neither a revision-driven catalyst nor a risk. The gap between current consensus and guidance is narrow, leaving the Q2 print itself (and any guidance raise) as the primary driver.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (May 5, 2026) | Current Consensus (Jul 29, 2026) | Estimate Delta (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Delta | Consensus vs. Guidance (%) |
Net Sales (Q2 2026) | $2.646B | $2.636B | -0.4% | Slightly negative organic (NA CMG); no explicit $ guide | Unchanged | No change | Consistent |
Adj. EPS (Q2 2026) | $1.431 | $1.432 | +0.1% | No explicit Q2 EPS guide | Unchanged | No change | N/A |
Net Sales (FY2026) | $12.252B | $12.239B | -0.1% | 2-4% algorithm growth range | Unchanged | No change | Consensus at low end of algorithm range |
Adj. EPS (FY2026) | $8.444 | $8.431 | -0.2% | Mid-teens growth off depressed 2025 base | Unchanged | No change | Consistent with guidance |
NA Confectionery Organic Growth (Q2 2026) | -1.5% | -1.9% | -0.4 pts | Slightly negative (explicit) | Unchanged | No change | Consistent with guidance |
Estimates have barely moved since the Q1 print — all key metrics within 0.4% of the post-earnings baseline. This flat revision trajectory reflects the street's confidence that management's guidance is credible, but also means there is no estimate-revision tailwind heading into the print. The key question is whether a guidance raise at the midyear mark unlocks upward revisions for FY2026.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: HSY has underperformed both XLP and the S&P 500 since the Q1 earnings date (Apr 30, 2026), declining ~1% vs. XLP +3.6% and SPY +1.5%, driven by sentiment and multiple compression rather than estimate revisions — the stock peaked at ~107 (indexed) in late May before selling off ~15 points to a trough in mid-July, suggesting the market is skeptical of the recovery narrative.
HSY vs. XLP (Consumer Staples ETF) vs. S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings Date (April 30, 2026). Source: Stock Price Data.
Since the Q1 2026 earnings date, HSY peaked at ~106.5 (indexed) on May 27 before declining sharply through June and into mid-July, reaching a trough of ~91.7 on July 15. The stock has partially recovered to ~99 as of July 29. The underperformance vs. XLP is notable given that HSY beat Q1 estimates by a wide margin — the negative stock reaction on earnings day (despite the beat) and subsequent drift lower suggest the market is pricing in execution risk on the gross margin recovery and skepticism about a guidance raise. The Goldman Sachs Global Staples Forum (May 12) did not produce any material guidance update, which may have disappointed investors expecting a more bullish tone.
Source: Stock Price Data (Yahoo Finance).
Key Takeaway: Peer commentary from Mondelez (Q2 2026 earnings, July 28) is the most directly relevant read-through — MDLZ reported positive volume mix in North America and cocoa surplus at historical highs, both constructive signals for HSY's gross margin recovery narrative. General Mills and Campbell's flag a pressured but stable consumer with value-seeking behavior, consistent with HSY's elasticity commentary.
Relevance: Highest read-through — direct competitor in chocolate/confectionery; reports same calendar quarter as HSY Q2 2026.
Relevance: Broad CPG peer; commentary covers the same calendar period as HSY Q2 2026 (GIS Q4 FY2026 ends May 2026).
Relevance: CPB Q3 FY2026 covers the February–April 2026 period; commentary on consumer trends and promotional dynamics is relevant context for HSY's Q2 2026 (April–June 2026).
Relevance: COST covers the February–May 2026 period; candy category commentary is a direct channel read-through.
Relevance: SFM covers the same calendar quarter as HSY Q2 2026; commentary on consumer behavior and affordability is relevant context.
Key Takeaway: The most important development since Q1 earnings is the absence of a guidance raise at the Goldman Sachs Staples Forum (May 12) — management stayed silent on any update, which the market interpreted negatively. The Q2 print is now the first opportunity to raise guidance, making it the single most important catalyst.
Key Takeaway: The dominant signal is persistent, high-frequency 10b5-1 selling by the Hershey Trust (10,000 shares/day, every trading day since at least April 30) — this is a structural, plan-driven disposition and carries no informational signal. The only notable discretionary activity is CFO Steven Voskuil's three 10b5-1 planned sales (1,500 shares each in May, June, and July), also plan-driven. No open-market buys from any insider.
Name | Title | Transaction Type | Shares | Date | Note |
Hershey Trust Co. (Milton Hershey School) | 10% Owner | 10b5-1 Planned Sale (ongoing) | 10,000 shares/day (every trading day) | Apr 30 – Jul 29, 2026 | Structural 10b5-1 plan; ~600,000 shares sold over the period. No informational signal — routine Trust disposition to fund Milton Hershey School operations. |
Voskuil Steven E | SVP, Chief Financial Officer | 10b5-1 Planned Sale | 1,500 shares | May 18, 2026 | 10b5-1 plan; routine scheduled sale. |
Voskuil Steven E | SVP, Chief Financial Officer | 10b5-1 Planned Sale | 1,500 shares | Jun 18, 2026 | 10b5-1 plan; routine scheduled sale. |
Voskuil Steven E | SVP, Chief Financial Officer | 10b5-1 Planned Sale | 1,500 shares | Jul 20, 2026 | 10b5-1 plan; routine scheduled sale. |
Arends Mitchell Andrew | SVP, Chief Supply Chain Officer | Award (Grant) | 3,843 shares | Jul 8, 2026 | Compensation award (code A); not a market purchase. No informational signal. |
Multiple Directors (Brandt, Curoe, Kraus, Mahlan, Nalebuff, Ozan, Park, Persaud, Quintero-Johnson, Robbin-Coker, Singleton) | Directors | Award (Grant) | ~252–391 shares each | Jul 1, 2026 | Routine annual director compensation grants (code A); not open-market purchases. No informational signal. |
Summary: No open-market buys from any insider during the period. All selling activity is 10b5-1 plan-driven (Hershey Trust and CFO Voskuil) and carries no informational signal. Director grants are routine annual compensation. The absence of any discretionary open-market buying by management is notable given the stock's ~15% decline from its May peak, but is not unusual given the Trust's structural selling program and the pre-earnings quiet period.
Source: Insider Transaction Data (SEC Form 4).